Updated: Oct 1, 2009
Felons are closed-space infections of the fingertip pulp.
Fingertip pulp is divided into numerous small compartments by vertical septa that stabilize the pad. Infection occurring within these compartments can lead to abscess formation, edema, and rapid development of increased pressure in a closed space. This increased pressure may compromise blood flow and lead to necrosis of the skin and pulp.
Felons and paronychias account for approximately one third of all hand infections. Thumb and index finger are the most commonly affected digits.
With skin necrosis, spontaneous decompression may occur. When skin does not yield, osteomyelitis, tenosynovitis, and septic arthritis may result.
Cellulitis
Fingertip Injuries
Herpetic Whitlow
Paronychia
The goals of pharmacotherapy are to treat infections and prevent further complications.
Empirical coverage for S aureus and streptococcal organisms should be provided. Given the rapid emergence of community-acquired methicillin-resistant S aureus, treatment with a drug more likely to be effective against this agent should be considered. Coverage for E corrodens may be indicated for immunosuppressed patients.
Bactericidal antibiotic that inhibits cell wall synthesis; DOC to treat infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when staphylococcal infection is suspected.
250-500 mg PO qid
25-50 mg/kg/d PO qid
Decreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin levels
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Monitor PT in patients taking anticoagulant medications; toxicity may increase in patients renally impaired
An alternative antibiotic that inhibits RNA-dependent protein synthesis, possibly by stimulating dissociation of peptidyl tRNA from ribosomes, which inhibits bacterial growth.
Indicated for the treatment of infections caused by susceptible strains, including streptococci and S aureus.
In children, age, weight, and severity of infection determine proper dosage. When twice a day dosing is desired, half-total daily dose may be taken every 12 h. For more severe infections, double dose.
250-1000 mg PO qid
30-50 mg/kg/d PO qid
Coadministration may increase toxicity of theophylline, digoxin, carbamazepine, and cyclosporine; may potentiate anticoagulant effects of warfarin; coadministration with lovastatin and simvastatin increases risk of rhabdomyolysis
Documented hypersensitivity; hepatic impairment
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in liver disease; estolate formulation may cause cholestatic jaundice; GI adverse effects are common (give doses pc); discontinue use if nausea, vomiting, malaise, abdominal colic, or fever occur
Another alternative antibiotic. First-generation cephalosporin that inhibits bacterial replication by inhibiting bacterial cell wall synthesis. Bactericidal and effective against rapidly growing organisms forming cell walls.
250-500 mg PO qid
25-50 mg/kg/d PO qid
Coadministration with aminoglycosides increases nephrotoxic potential
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in renal impairment
Indicated for severe infections.
Treats infections caused by penicillinase-producing staphylococci. Used to initiate therapy in any patients with possible penicillin G-resistant staphylococcal infection. Do not use for treatment of penicillin G-susceptible staphylococcal organisms.
Use parenteral therapy initially in severe infections. Severe infections may require very high doses.
Change to oral therapy as condition improves.
Because of occasional occurrence of thrombophlebitis associated with the parenteral route, particularly in elderly patients, administer parenterally only for a short term (24-48 h) and change to oral route if clinically possible.
1-2 g IV q4h
100-200 mg/kg/d IV qid
Associated with warfarin resistance when administered concurrently; effects may decrease with bacteriostatic action of tetracycline derivatives
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
To optimize therapy, determine causative organisms and susceptibility; >10 d treatment to eliminate infection and prevent sequelae (eg, endocarditis, rheumatic fever); take cultures after treatment to confirm that infection is eradicated
Inhibits bacterial growth by inhibiting synthesis of dihydrofolic acid.
160 mg TMP PO/IV q12h
<2 years: Do not administer
>2 years: 6-12 mg TMP/kg/d PO/IV divided bid
May increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; coadministration of diuretics increases incidence of thrombocytopenia purpura in elderly persons; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine
Documented hypersensitivity; megaloblastic anemia due to folate deficiency
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Do not use during last trimester of pregnancy due to potential toxicity to newborn (eg, jaundice, hemolytic anemia, kernicterus)
Dosage adjustments (adult adjustments)
CrCl (mL/min) 80-50: Recommended IV dose q18h
CrCl 50-10: Recommended IV dose q24h
CrCl <10: Not recommended
During peritoneal dialysis: 0.16-0.8 g q48h
Discontinue at first appearance of skin rash or sign of adverse reaction; obtain CBCs frequently; discontinue therapy if significant hematologic changes occur; goiter, diuresis, and hypoglycemia may occur with sulfonamides; prolonged IV infusions or high doses may cause bone marrow depression (if signs occur, give 5-15 mg/d leucovorin); caution in folate deficiency (eg, chronic alcoholics, elderly, those receiving anticonvulsant therapy, or those with malabsorption syndrome); hemolysis may occur in G-6-PD deficient individuals; AIDS patients may not tolerate or respond to TMP-SMZ; caution in renal or hepatic impairment (perform urinalyses and renal function tests during therapy); give fluids to prevent crystalluria and stone formation
Connolly B, Johnstone F, Gerlinger T, Puttler E. Methicillin-resistant Staphylococcus aureus in a finger felon. J Hand Surg [Am]. Jan 2000;25(1):173-5. [Medline].
Barkin JA, Miki RA, Mahmood Z, Landy DC, Owens P. Prevalence of methicillin resistant Staphylococcus aureus in upper extremity soft tissue infections at jackson memorial hospital, miami-dade county, Florida. Iowa Orthop J. 2009;29:67-73. [Medline].
Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. Mar 2008;51(3):291-8. [Medline].
Newfield RS, Vargas I, Huma Z. Eikenella corrodens infections. Case report in two adolescent females with IDDM. Diabetes Care. Sep 1996;19(9):1011-3. [Medline].
Glickel SZ. Hand infections in patients with acquired immunodeficiency syndrome. J Hand Surg [Am]. Sep 1988;13(5):770-5. [Medline].
Bolton H, Fowler PJ, Jepson RP. Natural history and treatment of pulp space infection and osteomyelitis of the terminal phalanx. J Bone Joint Surg. 1949;4:499-504.
Canales FL, Newmeyer WL, Kilgore ES. The treatment of felons and paronychias. Hand Clin. Nov 1989;5(4):515-23. [Medline].
Clark DC. Common acute hand infections. Am Fam Physician. Dec 1 2003;68(11):2167-76. [Medline].
Elston DM. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm. J Drugs Dermatol. Nov-Dec 2005;4(6 Suppl):s15-9. [Medline].
Hijjawi JB, Dennison DG. Acute felon as a complication of systemic paclitaxel therapy: case report and review of the literature. Hand (N Y). Sep 2007;2(3):101-3. [Medline].
Kilgore ES Jr, Brown LG, Newmeyer WL. Treatment of felons. Am J Surg. Aug 1975;130(2):194-8. [Medline].
Perry AW, Gottlieb LJ, Zachary LS, Krizek TJ. Fingerstick felons. Ann Plast Surg. Mar 1988;20(3):249-51. [Medline].
Roberge RJ, Weinstein D, Thimons MM. Perionychial infections associated with sculptured nails. Am J Emerg Med. Oct 1999;17(6):581-2. [Medline].
Watson PA, Jebson PJ. The natural history of the neglected felon. Iowa Orthop J. 1996;16:164-6. [Medline].
Zyluk A, Puchalski P. [Severe infections within the upper extremity--analysis of the causes and methods of treatment]. Chir Narzadow Ruchu Ortop Pol. 2006;71(4):239-44. [Medline].
felon, paronychia, fingertip infection, finger infection, closed-space infections, fingertip pulp, paronychias, hand infections, osteomyelitis, tenosynovitis, septic arthritis, Staphylococcus aureus, S aureus, Eikenella corrodens, E corrodens, wood splinter, minor cut, cellulitis, skin necrosis
Glen Vaughn, MD, Director, Department of Emergency Medicine, Defiance Hospital
Disclosure: Nothing to disclose.
Jeffrey Glenn Bowman, MD, MS, Consulting Staff, Highfield MRI, Columbus, Ohio
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Jon Mark Hirshon, MD, MPH, Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine
Jon Mark Hirshon, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Steven C Dronen, MD, FAAEM, Director of Emergency Services, Director of Chest Pain Center, Department of Emergency Medicine, Ft Sanders Sevier Medical Center
Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)